Sipa1l3 inhibitors are a class of chemical compounds designed to target and block the function of the signal-induced proliferation-associated 1-like 3 (Sipa1l3) protein. Sipa1l3 is a member of the SIPA1 family of proteins, which are known to act as Rap GTPase-activating proteins (RapGAPs). These proteins are involved in regulating small GTPases of the Rap family, which play crucial roles in controlling cell adhesion, migration, and cytoskeletal dynamics. Sipa1l3, in particular, is associated with processes involving cell-cell junctions, particularly in epithelial tissues, where it helps regulate the organization and stability of cell adhesion complexes. By inhibiting Sipa1l3, these compounds interfere with its ability to modulate Rap signaling pathways, potentially altering how cells maintain and adjust their adhesion and structural integrity in response to environmental cues.
The development of Sipa1l3 inhibitors is based on an understanding of the protein's structural and functional domains, particularly its RapGAP domain, which is responsible for inactivating Rap GTPases by accelerating the hydrolysis of GTP to GDP. Researchers utilize techniques such as molecular modeling, X-ray crystallography, and computational docking to identify key binding pockets within this domain where inhibitors can attach. These inhibitors are designed to specifically interact with these critical regions, blocking Sipa1l3's GTPase-activating function and thereby disrupting its role in regulating Rap-dependent cellular processes. Once synthesized, the inhibitors are tested in vitro to assess their binding affinity, selectivity, and ability to inhibit Sipa1l3's activity in biochemical assays. By inhibiting Sipa1l3, researchers can gain insights into its role in cellular signaling, particularly in the regulation of cell adhesion, migration, and the maintenance of tissue structure. The study of these inhibitors sheds light on the broader role of RapGAPs in cell signaling networks and the complex regulation of cytoskeletal dynamics and cell junction stability.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, potentially affecting pathways involved in cell growth and proliferation, which SIPA1L3 might influence. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, could indirectly affect signaling pathways associated with SIPA1L3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, potentially modulating signaling pathways that SIPA1L3 is involved in, particularly those related to cell survival and proliferation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, which may influence pathways associated with stress response and apoptosis, potentially relevant to SIPA1L3 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor, could indirectly modulate the MAPK/ERK pathway, possibly affecting SIPA1L3's role in cell signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, potentially affecting the same pathway as U0126 and thereby influencing SIPA1L3 activity indirectly. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, might modulate stress response pathways potentially connected to SIPA1L3 function. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt processing and secretion, potentially affecting pathways that SIPA1L3 could be involved in, such as cell adhesion and migration. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, could modulate cytoskeleton organization and cell migration, processes that SIPA1L3 might influence. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Rac1 inhibitor, potentially affecting cell migration and adhesion, relevant to the functional scope of SIPA1L3. | ||||||